DiscoverRumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals
Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals
Claim Ownership

Rumor vs Truth - Evidence‑Based Mythbusting for Healthcare Professionals

Author: TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter

Subscribed: 29Played: 203
Share

Description

Your trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.

This podcast series from TRC Healthcare, the team behind Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights products, is designed to help pharmacists, pharmacy technicians, prescribers, and even patients navigate some of the claims they might see about medication therapy. 

Find the video version of this show on YouTube: https://www.youtube.com/@trc.healthcare 


TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

28 Episodes
Reverse
Generic Meds

Generic Meds

2026-09-1531:02

Generic drugs save money, but do they lower the bar? From what "bioequivalent" really requires to why an authorized generic can look just like the brand name, a lot of what gets assumed about generic drugs hasn't caught up with how tightly this corner of pharmacy is actually regulated. In this episode, Don and Steve pick apart the claims pharmacists hear most about generic drugs. 🔬 Do generics really get held to a lower approval or quality bar than the brand drug?📦 Is an authorize...
Naloxone and nalmefene are reaching more hands than ever—through bystander programs, pharmacy dispensing protocols, and over-the-counter sales. But as access expands, one question keeps coming up: Does easier access to naloxone or nalmefene actually make opioid misuse worse? In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about whether increasing naloxone and nalmefene access encourages opioid misuse or overdose. Hosts Don Weinberger, PharmD, and Steve Small, Ph...
Opioids

Opioids

2026-08-1824:22

Opioid Rules of Thumb Are Sticky—Even When the Evidence Moves On. From how quickly dependence risk starts to whether the newest non-opioid really replaces an opioid, a lot of advice is still running on assumptions learned years ago. In this episode, Don and Steve separate opioid fact from folklore by challenging long-held assumptions with the latest evidence. 💊 How fast can dependence risk start after a first prescription? 🆕 Does suzetrigine (Journavx) give opioi...
Send us Fan Mail Can polyethylene glycol (PEG 3350, Miralax) affect the absorption of other medications? In this BONUS mailbag episode of Rumor vs Truth, we answer a listener question about whether polyethylene glycol (PEG 3350) should be separated from other medications and, if so, by how long. Hosts Don Weinberger, PharmD and Steve Small, PharmD break down what the evidence actually shows about laxatives, intestinal transit time, and medication absorption. Together, they discuss: Can PEG 33...
Laxatives

Laxatives

2026-07-2127:30

The Constipation Conversation Has Been Backed Up for Years. From fears about laxative dependence to questions about pediatric safety, some laxative myths are still stuck in the system… despite growing evidence to the contrary. In this episode, Don and Steve tackle some of the most common claims healthcare professionals hear about constipation treatment—and explore what the research really says. 💩 Why does docusate remain so popular if the evidence is questionable?⚠️ Should patients worr...
loading
Comments